Skip to main content
Year archive

Marinomed Biotech AG — 2021 filings

All 44 regulatory filings released by Marinomed Biotech AG (MARI) in 2021, sourced directly from the official regulator.

44 Filings
2021 Period
2021 filings (44)
Filing Released Lang
Director's Dealing 2021
Director's Dealing
2021-12-17 English
Director's Dealing 2021
Director's Dealing
2021-12-17 German
Marinomed and Friedrich-Alexander-Universitat Erlangen-Nurnberg publish new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern
Regulatory Filings
2021-12-09 English
Director's Dealing 2021
Director's Dealing
2021-12-03 English
Director's Dealing 2021
Director's Dealing
2021-12-03 German
Director's Dealing 2021
Director's Dealing
2021-12-03 English
Director's Dealing 2021
Director's Dealing
2021-12-03 German
Director's Dealing 2021
Director's Dealing
2021-12-03 English
Director's Dealing 2021
Director's Dealing
2021-12-03 German
Marinomed to present at Munich capital market conference (MKK)
Report Publication Announcement
2021-12-01 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-30 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-11-30 German
Marinomed Biotech AG Reports Significant Revenue Growth for the First 9 Months 2021
Earnings Release 9M 2021
2021-11-22 English
Solv4U: Marinomed launches new business area enabling the development of innovative formulations in technology partnerships
M&A Activity
2021-11-03 English
Marinomed updates financial calendar and participates in upcoming industry and investor conferences
Report Publication Announcement
2021-10-28 English
Marinomed partners with Perrigo to distribute virus-blocking Carragelose nasal spray in Scandinavia and France
Regulatory Filings
2021-10-27 English
First Marinosolv(R) platform deal: Marinomed Biotech AG and Luoxin Pharmaceutical Group Stock Co., Ltd. sign agreement on Budesolv to treat allergic rhinitis in Greater China
Regulatory Filings
2021-10-20 English
Marinomed Biotech AG signs financing agreement with Nice & Green S.A. to advance its scientific and clinical programs
Capital/Financing Update
2021-10-05 English
Capital/Financing Update 2021
Capital/Financing Update
2021-10-04 English
Capital/Financing Update 2021
Capital/Financing Update
2021-10-04 German
Marinomed's Investor Relations to be Strengthened by Stephanie Kniep
Board/Management Information
2021-09-23 English
Marinomed Biotech AG publishes clinical data on efficacy of Carragelose lozenges against respiratory viruses including SARS-CoV-2 in the International Journal of General Medicine
Report Publication Announcement
2021-09-09 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-25 German
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-25 English
Marinomed Biotech AG Reports Financial Results for 1st Half 2021 with significant revenue growth
Report Publication Announcement H1 2021
2021-08-25 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-30 German
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-07-30 English
Marinomed Biotech AG announces grant of Chinese Patent covering the proprietary Marinosolv technology to generate aqueous solutions from insoluble compounds
Regulatory Filings
2021-07-15 English
Marinomed Biotech AG expands distribution of Corona virus blocker Carragelose into Brazil and Mexico
Regulatory Filings
2021-07-06 English
Marinomed Biotech AG Reports Encouraging Topline Data for Phase II Clinical Trial of Tacrosolv in Allergic Rhinoconjunctivitis
Legal Proceedings Report
2021-07-01 English
Marinomed Biotech AG Reports Financial Results for 1st Quarter 2021: Growth in Sales, due to persistent strong demand in Carragelose-based virus blockers
Earnings Release Q1 2021
2021-05-26 English
AGM Information 2021
AGM Information
2021-05-18 German
AGM Information 2021
AGM Information
2021-05-18 English
Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants
Regulatory Filings
2021-04-21 English
Annual Report (ESEF) 2020
Annual Report (ESEF) FY 2020
2021-04-14 German
Marinomed Biotech AG Reports Financial Results for Fiscal Year 2020 and Record Sales For Virus Blocker Carragelose
Earnings Release FY 2020
2021-04-14 English
Last Patient Completes Marinomed Biotech AG's Phase II Clinical Trial of Tacrosolv to Treat Ocular Hay Fever Symptoms
Regulatory Filings
2021-04-12 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-02-23 German
Earnings Release 2021
Earnings Release FY 2021
2021-02-19 English
Regulatory Filings 2021
Regulatory Filings
2021-02-19 German
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-26 German
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-26 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-25 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-25 German